跳至主要内容
临床试验/ACTRN12624000293561
ACTRN12624000293561尚未招募Unknown

A Pilot Feasibility randomised controlled trial of Patient-Reported Outcome Measure Monitoring and Feedback to Improve Disability and Quality of Life in Critically Ill Patients Who Survive Extracorporeal Membrane Oxygenation (ECMO)

Alfred Health0 个研究点目标入组 40 人开始时间: 2024年3月21日最近更新:
适应症

试验速览

阶段
Unknown
状态
尚未招募
发起方
Alfred Health
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Blinded (masking used)

入排标准

年龄范围
18 Years 至 o limit(—)
性别
All

入选标准

  • 1. Received ECMO therapy in ICU for >24 hours;
  • 2. Adults aged 18 years old or more.
  • 3. Expected to survive to hospital discharge;
  • 4. Enrolled in the EXCEL registry.

排除标准

  • Documented pre-existing medical diagnosis of cognitive impairment e.g. dementia;
  • Not expected to reside in Australia for 12 months following randomisation;
  • No regular GP or unable to identify a primary care practice.
  • Patient opts out of EXCEL Registry’s long-term follow up
  • Hospital length of stay >5 months post ECMO commencement

研究者

发起方
Alfred Health

相似试验

Patient-Reported Outcome Measure Monitoring and... | 临床试验